While a one-stop shop still has its advantages, sponsor companies and CDMOs are starting to see each other not as transactional relationships, but true partners…
News Category: Media
Aragen talks manufacturing in Bangalore as qualification nears
Last month, BioProcess Insider had a chance to speak with Subodh Deshmukh, CEO of Biologics at Aragen Bioscience about his company’s contract development and manufacturing organization (CDMO)…
Avendus, SBI Life pick up over 2.5% secondaries in Aragen for Rs 300 crore
Bengaluru: Avendus Future Leaders Fund (FLF) III, part of the Avendus Group, and SBI Life Insurance have co-led a Rs 300 crore investment in Hyderabad-headquartered…
US tariffs could undo generic drugmakers’ efforts to be less reliant on Chinese raw materials, experts say
There is the long-term threat that US tariffs could lead Indian generic drugmakers to move back to getting most of their APIs from China, which…
India’s CDMOs, CRDMOs to benefit from global biopharma’s increased outsourcing: report
Indian contract development and manufacturing organizations (CDMOs) and contract research, development and manufacturing organizations (CRDMOs) are poised for sustained growth through fiscal 2026, amid supply…
Aragen Life Sciences eyes IPO as it expands global footprint with biologics, ADCs
The Hyderabad-based CRDMO is betting on its recently announced capacity expansion for biologics and high-demand antibody drug conjugates or ADCs, to leverage the shift. Summary…
The Evolving Science Behind Formulation Development
Bringing new chemical entities (NCEs) from discovery all the way to the clinical trial stage requires deep knowledge in drug substance characterization, phase-appropriate formulations, and…
Advanced Strategies for Balancing Yield, Stability, and Quality in ADC Production
Antibody–drug conjugates (ADCs) are a now-proven therapeutic approach that has added several commercial products to the oncologist’s toolbox. Behind the scenes, ADC manufacturing continues to…
Accelerating Vaccine Development with Cutting-edge R&D to Support Global Health Initiatives
Aragen Life Sciences stands at the forefront of innovation in biologics development and manufacturing, delivering cutting-edge solutions to the global vaccine industry. We spoke to Dr. Satinder…
Aspire to Inspire
Aragen’s ESG journey-challenges faced, milestones achieved, and what comes next: At Aragen, sustainability is not a parallel agenda-it is the way the company builds science,…
